Mizuho reaffirms Spcx outperformance at $200 and JPMorgan raise its target to $240
Mizuho reaffirms Spcx outperformance at $200 and JPMorgan raise its target to $240 Piper Sandler, however, cut its target to $140 (Neutral) citing a sharp rise in tradable shares, elevated FY27 capex, and uncertainty around AI cloud contracts that could pressure the stock until the 2027 lock-up expires Source
The excerpt is quoted from a public Telegram channel, which owns its text.